# Early Aggressive Invasive Intervention for Atrial Fibrillation

> **NCT02825979** · NA · UNKNOWN · sponsor: **Jason Andrade** · enrollment: 303 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **PROCEDURE:** Cryoballoon-based PVI
- **DRUG:** Anti-Arrhythmic Drug Therapy

## Key facts

- **NCT ID:** NCT02825979
- **Lead sponsor:** Jason Andrade
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01
- **Primary completion:** 2022-09
- **Final completion:** 2022-11
- **Target enrollment:** 303 (ACTUAL)
- **Last updated:** 2022-10-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02825979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02825979, "Early Aggressive Invasive Intervention for Atrial Fibrillation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02825979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*